Core Insights - CareCloud has raised its revenue outlook for 2025 to a range of $116 million to $118 million, up from the previous guidance of $111 million to $114 million, indicating strong growth in the hospital IT market [2][3] - The company anticipates 2026 revenue to be between $128 million and $130 million, driven by cross-selling opportunities and increased hospital adoption of its AI-driven solutions [2][3] - The acquisition of Medsphere Systems Corporation is highlighted as a transformative move that enhances CareCloud's product portfolio and market demand [3] Financial Guidance - For 2025, CareCloud expects revenue between $116 million and $118 million, reflecting an increase in scale and market participation [2] - The anticipated revenue for 2026 is projected to be $128 million to $130 million, supported by ongoing investments in AI innovation [2] - Adjusted EBITDA outlook is expected to remain unchanged, while GAAP EPS may be affected by higher non-cash amortization expenses due to the acquisition [2] Strategic Initiatives - CareCloud's AI Center of Excellence is advancing tools that automate revenue cycle workflows and support clinicians in real-time, aimed at improving efficiency and patient outcomes [3] - The company emphasizes its commitment to innovation in healthcare technology, helping clients enhance financial and operational performance [4] - CareCloud serves over 40,000 providers, focusing on reducing administrative burdens and improving patient care [4]

Core Points - Scryb Inc. will proceed with a share consolidation on a basis of one new common share for every ten old common shares, effective August 13, 2025 [1][2] - The company currently has 323,187,472 common shares issued and outstanding, which will reduce to approximately 32,318,731 common shares post-consolidation [3] - No fractional common shares will be issued; any resulting fractions will be rounded down to the nearest whole number without cash compensation [3] - TSX Trust Company will send a Letter of Transmittal to shareholders for exchanging pre-consolidation share certificates for post-consolidation certificates [4] Company Overview - Scryb Inc. invests in and supports a portfolio of ventures across AI, biotech, digital health, and cybersecurity [5]

Core Insights - CareCloud, Inc. has reported its first quarter of positive GAAP EPS in its history since going public, indicating a significant milestone in financial performance [1][6][9] - The company has launched an AI Center of Excellence aimed at enhancing operational efficiency and driving innovation in healthcare technology [5][6][7] - CareCloud's financial results show strong growth, with a GAAP net income of $2.9 million for Q2 2025, a 73% increase from Q2 2024 [6][7] Financial Performance - GAAP net income for Q2 2025 was $2.9 million, up from $1.7 million in Q2 2024, representing a 73% increase [6] - Positive GAAP EPS of $0.04 per share compared to a negative GAAP EPS of ($0.14) per share in Q2 2024 [6] - Revenue for Q2 2025 was $27.4 million, slightly down from $28.1 million in Q2 2024 [6] - Year-to-date revenue for 2025 reached $55.0 million, compared to $54.1 million in the same period last year [6] Strategic Initiatives - The AI Center of Excellence is expected to scale to 500 team members by year-end, focusing on automating clinical workflows and optimizing revenue cycle management [5][6] - CareCloud has completed two acquisitions in 2025 and is actively evaluating additional opportunities to enhance its market position [6][7] - The company continues to pay preferred stock dividends monthly from internally generated free cash flow, demonstrating financial stability [7] Guidance and Future Outlook - CareCloud reaffirms its revenue guidance for 2025, expecting between $111 million and $114 million [9][10] - Adjusted EBITDA is projected to be between $26 million and $28 million for the full year 2025 [10] - GAAP EPS is anticipated to be in the range of $0.10 to $0.13 for the fiscal year ending December 31, 2025 [9][10]

Core Points - CareCloud has surpassed the accelerated filer threshold with a public float of $85.1 million as of June 30, 2025, triggering new compliance requirements under SEC regulations [1] - The achievement is seen as a validation of CareCloud's growth trajectory and investor confidence, with a commitment to compliance and corporate governance emphasized by the Co-CEO [2] - The current audit firm cannot perform the required ICFR attestation, necessitating a change in auditors to ensure compliance [2] - CareCloud has initiated a process to engage a new audit firm capable of fulfilling the necessary services for fiscal year 2025 [3] Company Overview - CareCloud specializes in AI-driven healthcare technology solutions, helping over 40,000 providers enhance patient care while reducing administrative burdens and operating costs [4]

Core Insights - CareCloud, Inc. is participating in the "2025 Virtual Tech Conference" to discuss the impact of AI on healthcare delivery [1][2] - The conference will highlight how emerging growth companies are utilizing transformative technologies like AI and Quantum Computing for long-term success [3] Company Overview - CareCloud specializes in AI-driven healthcare technology solutions, aiming to enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4] - The company serves over 40,000 providers, focusing on reducing administrative burdens and operating costs while improving patient care [4] Conference Details - The Healthcare IT Panel featuring CareCloud is scheduled for June 3, 2025, at 11:00 a.m. EDT [1] - Participants must register as M-Vest members to attend the conference and view CareCloud's presentation [3]

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected three board members and approved executive compensation and the appointment of an accounting firm [1][2][3] - The re-elected board members include Anne Busquet, Bill Korn, and Lawrence Sharnak, all of whom have extensive experience in executive roles [2] - The shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Company Overview - CareCloud is a leader in healthcare technology solutions, providing services that enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4] - The Company serves over 40,000 providers, helping them reduce administrative burdens and operating costs while improving patient care [4]

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected Anne Busquet, Bill Korn, and Lawrence Sharnak to the Board for another two-year term [1][2] - Shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Group 1 - Anne Busquet has over 30 years of executive experience with American Express and Interactive Corp [2] - Bill Korn served as Chief Financial Officer for 10 years before retiring in October 2023 [2] - Lawrence Sharnak held various senior leadership roles at American Express for more than 30 years [2] Group 2 - CareCloud provides technology-enabled solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [4] - The Company serves over 40,000 providers, helping them improve patient care while reducing administrative burdens and operating costs [4]

Core Insights - CareCloud has been named Maxim Group's "Top Healthcare IT Pick for 2025" due to its transformative AI strategy and strong financial performance [1][2][3] - The company is trading at a 2026 EV/EBITDA multiple of 5.0x, significantly lower than the peer group average of 12.5x, indicating an attractive investment opportunity [2] - CareCloud's Q1 2025 performance showed a 52% year-over-year growth in adjusted EBITDA, highlighting its operational momentum [4] Company Strategy and Developments - CareCloud's AI Center of Excellence was launched with an initial team of over 50 AI professionals, aiming to scale to 500 by year-end, positioning the company as a leader in applied AI within healthcare [4] - The company emphasizes that AI is integrated into its core operations, enhancing documentation, revenue cycle management, patient engagement, and analytics [5] - CareCloud's AI suite, including tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, is highlighted as a key differentiator in the market [3] Financial Performance - The company has resumed preferred dividends and is returning to M&A-driven growth, contributing to its positive outlook [3] - CareCloud's commitment to delivering cost-effective technology aims to improve healthcare outcomes and operational efficiency for its clients [5] - More than 40,000 providers rely on CareCloud's solutions to enhance patient care while reducing administrative burdens [6]

Core Viewpoint - CareCloud, Inc. has declared monthly cash dividends for its Series A and Series B Preferred Stocks for March and April 2025, reflecting the company's commitment to returning value to shareholders [1][2]. Dividend Details - The monthly dividend for Series A Preferred Stock is $0.18229 per share for both March and April 2025, with an additional payment of $0.04688 per share [2]. - The monthly dividend for Series B Preferred Stock is also $0.18229 per share for both March and April 2025 [2][3]. - The ex-dividend and record dates for both series are March 31, 2025, and April 30, 2025, respectively, with payment dates set for April 15, 2025, and May 15, 2025 [2][4]. Preferred Stock Information - Series A Preferred Stock has a cumulative cash dividend rate of 8.75% per annum based on a $25.00 liquidation preference, equating to $2.1875 per annum per share [2][3]. - Series B Preferred Stock also has a cumulative cash dividend rate of 8.75% per annum based on a $25.00 liquidation preference, equating to $2.1875 per annum per share [3]. - The Series A Preferred Stock was converted into common stock on March 6, 2025, leading to its voluntary delisting from the Nasdaq Global Market [5]. Redemption Options - The company has the option to redeem Series A Preferred Stock at a price of $25.00 per share, plus any accumulated and unpaid dividends, with a notice period of 30 to 60 days [5]. - For Series B Preferred Stock, the redemption prices vary based on the date, starting at $25.50 per share for redemptions on or after February 15, 2025 [6].